Request Deal Involvement
Novozymes completed the acquisition of Chr. Hansen for $12.3bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Baker McKenzie
legal advisors
Gorrissen Federspiel
pr advisors
Impact Partners
financial advisors
Goldman Sachs
legal advisors to financial advisors
Freshfields Bruckhaus Deringer
legal advisors
Davis Polk & Wardwell
financial advisors
Nordea Bank
financial advisors
Gordon Dyal & Co
financial advisors
Danske Bank
legal advisors
Plesner
financial advisors
Oxera
legal advisors
Linklaters
pr advisors
FGS Global
pr advisors
Point Communications
legal advisors to financial advisors
Simpson Thacher & Bartlett
financial advisors
FIH Partners
or
Principals
target
CHR. HANSEN
bidder
NOVOZYMES AS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite